Amylyx Pharmaceuticals (NASDAQ:AMLX) is preparing for a pivotal Phase 3 readout for AVEXITIDE, its lead asset for post-bariatric hypoglycemia, or PBH, with data from the LUCIDITY trial expected in the third quarter, Co-Chief Executive Officer Joshua Cohen said at the BofA Annual Healthcare Conferenc
Infinity Natural Resources (NYSE:INR) said its first quarter was marked by a significant expansion of its Appalachian footprint, following the late-February closing of its acquisition of Antero’s Ohio Utica assets and the addition of working interests in Pennsylvania through the Chase acquisition.
JBS (NYSE:JBS) reported record first-quarter sales but lower profitability as executives said the global protein company faced difficult market conditions in U.S. beef, seasonal pressures, operational adjustments and shifting trade flows.
Global CEO Gilberto Tomazoni said the first quarter of 2026
Olin (NYSE:OLN) executives said the company expects a sharp sequential improvement in second-quarter earnings as higher pricing, seasonal demand and cost reductions begin to flow through results following a challenging but improving first quarter.
Speaking on Olin’s first-quarter 2026 earnings call
BitGo (NYSE:BTGO) reported sharply higher first-quarter revenue from a year earlier but a wider GAAP loss, as executives said softer digital asset market conditions and accounting treatment for new derivatives activity made headline results less reflective of the company’s underlying business trends
Doximity (NYSE:DOCS) reported fiscal fourth-quarter revenue above the high end of its guidance and said it is entering what management called an “AI investment year,” with higher spending planned for artificial intelligence products even as near-term growth in the digital pharma advertising market r
Leslie's, Inc. shares jumped 25.87% in after-hours trading after the company beat second-quarter revenue estimates by 13.97% and reported improved margins despite continued earnings pressure.
Wrap Technologies (NASDAQ:WRAP) said first-quarter revenue rose 45% year-over-year as product sales for its BolaWrap 150 line accelerated, while management reiterated its goal of doubling revenue in 2026.
On the company’s first-quarter 2026 earnings call, Chief Executive Officer Scot Cohen said man
USA Rare Earth (NASDAQ:USAR) said its first quarter was marked by a series of strategic transactions intended to turn the company into a fully integrated rare earths platform spanning mining, processing, metals and magnet production.
On the company’s first-quarter 2026 earnings call, Chief Executiv
Energous (NASDAQ:WATT) reported sharply higher first-quarter revenue and a narrower loss as management said the wireless power company is moving from technology validation into commercial deployment across enterprise Internet of Things markets.
On the company’s first earnings call since 2024, Chief
STAAR Surgical (NASDAQ:STAA) said its first quarter of 2026 marked a sharp rebound in sales and profitability, driven by strong demand in China, continued growth in the U.S. and tighter cost controls following a difficult 2025.
On the company’s earnings call, Interim Co-CEO, President and Chief Ope
QT Imaging (NASDAQ:QTI) reported sharply higher first-quarter 2026 revenue as scanner shipments more than doubled from the prior-year period, while management highlighted progress on reimbursement, regulatory approvals, software upgrades and international expansion during the company’s earnings call
Sangoma Technologies (NASDAQ:SANG) lowered its full-year fiscal 2026 revenue outlook and said its board has launched a structured strategic review, as management described a business increasingly split between growing communications infrastructure assets and more pressured software and UCaaS offerin
Seer (NASDAQ:SEER) reported lower first-quarter revenue but reaffirmed its full-year 2026 outlook, with management pointing to population-scale proteomics studies, an expanding publication base and expected second-half consumables demand as supports for the year.
Total revenue for the quarter ended
Rapid Micro Biosystems (NASDAQ:RPID) reported first-quarter 2026 revenue growth and reaffirmed its full-year outlook, citing momentum in system placements, consumables and recurring revenue, while management said gross margin improvement remains a central priority for the year.
President and Chief
Precigen (NASDAQ:PGEN) reported a sharp increase in first-quarter 2026 revenue as the company’s first commercial product, PAPZIMEOS, continued its U.S. launch following FDA approval in August 2025.
On the company’s earnings call, President and CEO Dr. Helen Sabzevari said PAPZIMEOS generated net pr
Omeros (NASDAQ:OMER) reported first-quarter 2026 net income of $56.1 million, or $0.78 per share, as the company began commercial sales of YARTEMLEA, its recently approved treatment for hematopoietic stem cell transplant-associated thrombotic microangiopathy, or TA-TMA.
Chairman and Chief Executive
Elizabeth Warren accused Donald Trump of treating taxpayer money like a "personal piggy bank" amid reports the DOJ may settle his $10 billion IRS lawsuit.
New Federal Reserve Chair Kevin Warsh may be viewed as aligned with the administration, but bettors believe there's a reasonable chance he could still face public pushback from President Donald Trump.
Bearings manufacturer RBC Bearings (NYSE:RBC) will be announcing earnings results this Friday before market open. Here’s what you need to know. RBC Bearings ...
The AI chipmaker's growth story is still extraordinary, but rising competition and a premium valuation make another name in the space look more attractive.
Microvision (NASDAQ:MVIS) said its first-quarter results showed early commercial traction from its expanded lidar portfolio following the acquisitions of Scantinel Photonics and lidar assets from Luminar Technologies, while management maintained its full-year revenue outlook and improved its cash bu
MDxHealth (NASDAQ:MDXH) reported first-quarter 2026 revenue of $27.4 million while announcing a strategic exit from its Resolve UTI testing business and the planned closure of its Plano, Texas, laboratory facility, a move executives said will sharpen the company’s focus on prostate cancer diagnostic
AEye (NASDAQ:LIDR) reported higher first-quarter revenue and emphasized expanding commercial engagement across defense, transportation, automotive and infrastructure markets, while management said the lidar company remains focused on converting evaluations and proofs of concept into deployments.
On
Lightwave Logic (NASDAQ:LWLG) reported a wider first-quarter loss while outlining progress on customer engagement, foundry integration and commercialization efforts for its electro-optic polymer technology, which management said is increasingly aligned with demand from artificial intelligence networ
